VXRT Vaxart Inc. Net earnings per share growth forecast for next year

VXRT (Vaxart Corp) - company brandmark

Vaxart, Inc. (VXRT) develops tablet-based vaccines for HPV and influenza, simplifying their storage and delivery. The consensus earnings per share trend visualizes market expectations, where the -16.90 level captures the latest values. Unique patents and strict FDA oversight serve as a moat for the business. Meanwhile, the sovereign development cycle minimizes macroeconomic influence, turning the asset into a reliable instrument.

VXRT - Vaxart Inc. Net earnings per share growth forecast for next year over the range 07/04/2022 - 07/19/2025

Analytical breakdowns for Vaxart Inc. (VXRT)

Basic company analysis:VXRT, Vaxart Inc.
Brand item of Vaxart

This indicator measures the consensus forecast for net income growth rates for the coming period, reflecting the mathematical sensitivity of market expectations to future cash flows. The current value of -16.90 within the context of Vaxart, Inc. (VXRT) and its unique oral vaccines and government grants allows for an assessment of patent monetization potential, while shifts in analyst expectations for EPS n+1 growth help identify the risk of overpaying for the asset in a timely manner.

Competitor analysis for Vaxart, Inc.

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year Cidara Therapeutics, Inc.|Net earnings per share growth forecast for next year Novavax Inc (NVAX)|Consensus forecast of earnings per share growth for next year CureVac|Valneva Pharma - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Vir Corp (VIR)|siga.com - Earnings growth forecast for next year|Expected net earnings per share growth next year emergentbiosolutions.com|AVIR: Earnings growth forecast for next year|IVVD (Invivyd Inc) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Enanta Pharmaceuticals|Inovio Pharma (INO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HLVX|KLRS (Kalaris Therapeutics Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year DYAI (Dyadic International)|Consensus forecast of earnings per share growth for next year NanoViricides, Inc. (NNVC)|TLPH - Net earnings per share growth forecast for next year|Cocrystal - Projected earnings per share increase next year|TRAW: Earnings growth forecast for next year|Dogwood Therapeutics, Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year QLGN|allovir.com (ALVR) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year VBI Vaccines Inc (VBIV)|VIRI - Expected net earnings per share growth next year